Towards holistic integrative medicine based management strategy of liver cirrhosis

References

• Davidoff F, Haynes B, Sackett D, et al. Evidence based medicine. BMJ. 1995 Apr 29;310(6987):1085–1086. doi: 10.1136/bmj.310.6987.1085. PubMed PMID: 7742666; PubMed Central PMCID: PMCPMC2549494.
   PubMed Web of Science ®Google Scholar
• Fan D. Holistic integrative medicine: toward a new era of medical advancement. Front Med. 2017 Mar;11(1):152–159. doi: 10.1007/s11684-017-0499-6. PubMed PMID: 28044221; eng.
   PubMed Web of Science ®Google Scholar
• Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1–85. PubMed PMID: 4950264.
   PubMedGoogle Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug;60(8):646–649. doi: 10.1002/bjs.1800600817. PubMed PMID: 4541913.
   PubMed Web of Science ®Google Scholar
• Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001 Feb;33(2):464–470. doi: 10.1053/jhep.2001.22172. PubMed PMID: 11172350.
   PubMed Web of Science ®Google Scholar
• Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008 Sep 4;359(10):1018–26. doi: 10.1056/NEJMoa0801209. PubMed PMID: 18768945; PubMed Central PMCID: PMCPMC4374557.
   PubMed Web of Science ®Google Scholar
• Kim WR, Mannalithara A, Heimbach JK, et al. MELD 3.0: the model for end-stage liver disease updated for the modern era. Gastroenterol. 2021 Dec;161(6):1887–1895 e4. doi: 10.1053/j.gastro.2021.08.050. PubMed PMID: 34481845; PubMed Central PMCID: PMCPMC8608337.
   PubMed Web of Science ®Google Scholar
• García-Pagán JC, Morillas R, Bañares R, et al. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT. Hepatol. 2003 Jun;37(6):1260–1266. doi: 10.1053/jhep.2003.50211. PubMed PMID: 12774003; eng.
   PubMed Web of Science ®Google Scholar
• García-Pagán JC, Villanueva C, Albillos A, et al. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial. Gut. 2009 Aug;58(8):1144–50. doi: 10.1136/gut.2008.171207. PubMed PMID: 19218249; eng.
   PubMed Web of Science ®Google Scholar
• Bureau C, Thabut D, Oberti F, et al. Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterol. 2017 Jan;152(1):157–163. doi: 10.1053/j.gastro.2016.09.016. PubMed PMID: 27663604; eng.
   PubMed Web of Science ®Google Scholar
• Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010 Mar 25;362(12):1071–81. doi: 10.1056/NEJMoa0907893. PubMed PMID: 20335583; eng.
   PubMed Web of Science ®Google Scholar
• Frenette C, Kayali Z, Mena E, et al. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis. J Hepatol. 2021 Feb;74(2):274–282. doi: 10.1016/j.jhep.2020.09.029. PubMed PMID: 33038432; eng.
   PubMed Web of Science ®Google Scholar
• Ding M, Yin Y, Wang X, et al. Associations of gallbladder and gallstone parameters with clinical outcomes in patients with cirrhosis. J Transl Int Med. 2023. In press. doi: 10.2478/jtim-2022-0076
   PubMed Web of Science ®Google Scholar
• Wang L, Guo X, Bai Z, et al. Impact of asymptomatic Superior mesenteric vein thrombosis on the outcomes of patients with liver cirrhosis. Thromb Haemost. 2022 Dec;122(12):2019–2029. doi: 10.1055/s-0042-1756648. PubMed PMID: 36179738; eng.
   PubMed Web of Science ®Google Scholar
• Jepsen P, Vilstrup H, Andersen PK. The clinical course of cirrhosis: the importance of multistate models and competing risks analysis. Hepatol. 2015 Jul;62(1):292–302. doi: 10.1002/hep.27598. PubMed PMID: 25376655; eng.
   PubMed Web of Science ®Google Scholar
• Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013 Feb 9;381(9865):468–475. doi: 10.1016/s0140-6736(12)61425-1. PubMed PMID: 23234725; eng.
   PubMed Web of Science ®Google Scholar
• de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022 Apr;76(4):959–974. doi: 10.1016/j.jhep.2021.12.022. PubMed PMID: 35120736; eng.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhao H, Deng Y, et al. Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis. J Hepatol. 2022 Dec;77(6):1564–1572. doi: 10.1016/j.jhep.2022.07.037. PubMed PMID: 36038017; eng.
   PubMed Web of Science ®Google Scholar
• Lai JC, Tandon P, Bernal W, et al. Malnutrition, frailty, and Sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the study of liver diseases. Hepatol. 2021 Sep;74(3):1611–1644. doi: 10.1002/hep.32049. PubMed PMID: 34233031; PubMed Central PMCID: PMCPMC9134787.
   PubMed Web of Science ®Google Scholar
• Tapper EB, Saleh ZM, Lizza S, et al. CAREGIVER randomized trial of two mindfulness methods to improve the burden and distress of caring for persons with cirrhosis. Dig Dis Sci. 2023 Sep;68(9):3625–3633. doi: 10.1007/s10620-023-08042-9. PubMed PMID: 37498415.
   PubMed Web of Science ®Google Scholar